Please provide your email address to receive an email when new articles are posted on . Empyrean Neuroscience Inc. has announced its launch as a genetic engineering company dedicated to developing ...

Scientists from Scripps Research report that they have carried out a study on a number of neuroactive compounds which might yield clues to the design of future psychiatric and neurological drugs.

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Delgiannidis and colleagues aimed to assess the efficacy ...

A potential cornucopia of neuroactive compounds, which might yield clues to the design of future psychiatric and neurological drugs, has become more accessible to synthetic chemists. A potential ...

Endophytic fungi, which live symbiotically within plant tissues without causing disease, have emerged as versatile factories for the production of neuroactive alkaloids. These nitrogen-containing ...

The Food and Drug Administration (FDA) has granted Fast Track designation to SAGE-217 (Sage Therapeutics) for the potential treatment of major depressive disorder (MDD). SAGE-217 is a novel, ...

For the first time, scientists discovered how neuroactive steroids naturally found in the brain and bloodstream inhibit the activity of a specific kind of protein called Toll-like receptors (TLR4), ...

A potential cornucopia of neuroactive compounds, which might yield clues to the design of future psychiatric and neurological drugs, has become more accessible to synthetic chemists, thanks to new ...

Thirty-seven inpatients were included in an open-label protocol (age: 51.5 ± 14.8 years, 23 women, 14 men). Patients met DSM-IV criteria for a major depressive episode. All patients gave their written ...

LA JOLLA, CA—A potential cornucopia of neuroactive compounds, which might yield clues to the design of future psychiatric and neurological drugs, has become more accessible to synthetic chemists, ...